IL1A and lung carcinoma: Overall, we propose that studies in GEMMs and humanized mice models should be employed to further delineate the mechanism of IL-1β in promoting lung cancer and to determine the efficacy of using IL-1 blockade therapies in combination with other treatments for lung adenocarcinoma.